Truly a global phenomenon, cannabis is finding devotees in all its incarnations, from recreational to hemp to medicinal (Israel, for example, recently passed Germany as the largest importer of medicinal flowers). There is practically no place in the world where demand does not tempt investors. At the same time, there are many countries that still outlaw the drug. And COVID-19 has created its own foreign investment barriers, from restrictions on retail and travel to supply chain disruptions. Various market research studies have tried to make sense out of the emerging international market. This session will tell you what we know, what we don’t know, and what the profit potential is from Africa to Asia to Europe to South America.
Moderator – Matt Lamers